$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

$boty Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000164033423001322 Filed on July 18, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$34.97K	$113.8K	$95.44K
YoY Change	83.09%	19.24%	243.59%
Cost Of Revenue	$9.170K	$33.83K	$96.25K
YoY Change	-69.01%	-64.85%	248.06%
Gross Profit	$25.80K	$79.97K	-$809.00
YoY Change	-345.95%	-9985.04%	-752.42%
Gross Profit Margin	73.78%	70.27%	-0.85%
Selling, General & Admin	$64.97K	$269.2K	$411.7K
YoY Change	-66.71%	-34.6%	76.64%
% of Gross Profit	251.82%	336.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$64.98K	$269.2K	$411.7K
YoY Change	-66.7%	-34.6%	76.64%
Operating Profit	-$39.18K	-$189.2K	-$412.5K
YoY Change	-80.95%	-54.12%	77.08%
Interest Expense	$743.9K	$1.967M	$626.7K
YoY Change	-90.91%	213.86%	130.33%
% of Operating Profit
Other Income/Expense, Net		$1.967M	-$3.111M
YoY Change		-163.22%	43.16%
Pretax Income	$704.7K	$1.778M	-$3.524M
YoY Change	-91.16%	-150.45%	46.45%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	$704.7K	$1.778M	-$3.524M
YoY Change	-91.16%	-150.45%	46.45%
Net Earnings / Revenue	2015.1%	1562.14%	-3692.06%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$1.184K
COMMON SHARES
Basic Shares Outstanding	3.535B shares	3.575B shares
Diluted Shares Outstanding		9.240B shares	8.883B shares

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.01K	$10.01K	$34.48K
YoY Change	-70.97%	-70.97%	732.85%
Cash & Equivalents	$10.01K	$10.01K	$34.48K
Short-Term Investments
Other Short-Term Assets	$0.00	$0.00	$7.500K
YoY Change	-100.0%	-100.0%
Inventory
Prepaid Expenses	$0.00
Receivables
Other Receivables
Total Short-Term Assets	$10.01K	$10.01K	$41.98K
YoY Change	-76.16%	-76.16%	914.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$10.01K	$10.01K	$41.98K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$10.01K	$10.01K	$41.98K
YoY Change	-76.16%	-76.16%	914.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$579.8K	$579.8K	$465.2K
YoY Change	24.64%	24.64%	19.68%
Accrued Expenses	$442.9K	$442.9K	$231.8K
YoY Change	91.03%	91.03%	-19.34%
Deferred Revenue
YoY Change
Short-Term Debt	$924.7K	$924.7K	$799.8K
YoY Change	15.62%	15.62%	50.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.915M	$4.915M	$6.841M
YoY Change	-28.16%	-28.16%	16.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.915M	$4.915M	$6.841M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.915M	$4.915M	$6.841M
YoY Change	-28.16%	-28.16%	16.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.943M
YoY Change	-15.17%
Common Stock	$3.712M
YoY Change	4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.905M	-$4.905M	-$6.799M
YoY Change
Total Liabilities & Shareholders Equity	$10.01K	$10.01K	$41.98K
YoY Change	-76.16%	-76.16%	914.01%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	$704.7K	$1.778M	-$3.524M
YoY Change	-91.16%	-150.45%	46.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$21.09K	-$87.99K	-$265.7K
YoY Change	-77.83%	-66.88%	236.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	18.52K	63.52K	$296.0K
YoY Change	-70.83%	-78.54%	652.22%
NET CHANGE
Cash From Operating Activities	-21.09K	-87.99K	-$265.7K
Cash From Investing Activities	0.000	0.000	$0.00
Cash From Financing Activities	18.52K	63.52K	$296.0K
Net Change In Cash	-2.570K	-24.47K	$30.34K
YoY Change	-91.88%	-180.66%	-176.68%
FREE CASH FLOW
Cash From Operating Activities	-$21.09K	-$87.99K	-$265.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7500	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	34800	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	boty	Promissory Note Debt Discount PromissoryNoteDebtDiscount	89183	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	51	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3535302536	shares
CY2021	us-gaap	Revenues Revenues	95436	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001407704
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	51	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3535302536	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3711714036	shares
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41981	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	7900	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	7900	usd
CY2021Q4	boty	Outstanding Warrants Balances Beginning OutstandingWarrantsBalancesBeginning	5556666666	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2020Q4	boty	Outstanding Warrants Exercise Price OutstandingWarrantsExercisePrice	0.0001
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-148005
CY2022	dei	Entity Registrant Name EntityRegistrantName	LINGERIE FIGHTING CHAMPIONSHIPS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-1399226
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	6955 North Durango Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1115-129
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89149
CY2022	dei	City Area Code CityAreaCode	702
CY2022	dei	Local Phone Number LocalPhoneNumber	505-0743
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1410381	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3711714036	shares
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	usd
CY2022Q4	boty	Accounts Payable And Accrued Liabilities AccountsPayableAndAccruedLiabilities	37098	usd
CY2021Q4	boty	Accounts Payable And Accrued Liabilities AccountsPayableAndAccruedLiabilities	20849	usd
CY2022Q4	boty	Accounts Payable Related Party AccountsPayableRelatedParty	542668	usd
CY2021Q4	boty	Accounts Payable Related Party AccountsPayableRelatedParty	465168	usd
CY2022Q4	boty	Promissory Note Debt Discount PromissoryNoteDebtDiscount	0	usd
CY2022Q4	boty	Romissory Notes Payable Current romissoryNotesPayableCurrent	340000	usd
CY2021Q4	boty	Romissory Notes Payable Current romissoryNotesPayableCurrent	250817	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	584730	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	549010	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3711714036	shares
CY2022	us-gaap	Revenues Revenues	113802	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	33831	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	96245	usd
CY2022	us-gaap	Gross Profit GrossProfit	79971	usd
CY2021	us-gaap	Gross Profit GrossProfit	-809	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	80962	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124645	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	68250	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	167010	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	269212	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	411655	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-189241	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-412464	usd
CY2022	us-gaap	Interest Expense InterestExpense	335953	usd
CY2021	us-gaap	Interest Expense InterestExpense	629690	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2302899	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2481400	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1777705	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3523554	usd
CY2022	boty	Basic And Diluted Income Loss Per Common Share BasicAndDilutedIncomeLossPerCommonShare	0.00
CY2021	boty	Basic And Diluted Income Loss Per Common Share BasicAndDilutedIncomeLossPerCommonShare	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	boty	Basic And Diluted Weighted Average Shares Of Common Stock Outstanding BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding	3575418028	shares
CY2021	boty	Basic And Diluted Weighted Average Shares Of Common Stock Outstanding BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding	2976633298	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9239631986	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8882874843	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5878867	usd
CY2021	boty	Shares Of Common Stock Issued For Conversion Of Debts And Accrued Interest Amount SharesOfCommonStockIssuedForConversionOfDebtsAndAccruedInterestAmount	309054	usd
CY2021	boty	Shares Of Common Stock Issued For Exercise Of Warrants Amount SharesOfCommonStockIssuedForExerciseOfWarrantsAmount	0	usd
CY2021	boty	Commitment Stock Issued Under Registration Rights Agreement Amount CommitmentStockIssuedUnderRegistrationRightsAgreementAmount	120060	usd
CY2021	boty	Write Off Of Convertible Notes And Accrued Interest WriteOffOfConvertibleNotesAndAccruedInterest	110076	usd
CY2021	boty	Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff	2064422	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3523554	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6798809	usd
CY2022	boty	Shares Of Common Stock Issued For Exercise Of Warrants Amount SharesOfCommonStockIssuedForExerciseOfWarrantsAmount	116486	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1777705	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4904618	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1777705	usd
CY2021	us-gaap	Profit Loss ProfitLoss	3523554	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	usd
CY2022	boty	Note Payable Issued As Equity Commitment Fee NotePayableIssuedAsEquityCommitmentFee	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	120060	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-2302899	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2481400	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	124904	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	462701	usd
CY2022	boty	Note Conversion Fee NoteConversionFee	0	usd
CY2021	boty	Note Conversion Fee NoteConversionFee	2000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7500	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-7500	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	77500	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	76500	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16249	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-44258	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	211049	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	166990	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87992	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-265661	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	63520	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	296000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63520	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24472	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	30339	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34481	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4142	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10009	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34481	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	boty	Debt Discount From Derivative Liabilities DebtDiscountFromDerivativeLiabilities	70520	usd
CY2021	boty	Debt Discount From Derivative Liabilities DebtDiscountFromDerivativeLiabilities	265000	usd
CY2022	boty	Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff	0	usd
CY2021	boty	Derivative Liabilities Reclass To Additional Paid In Capital Due To Note Conversion Warrant Exercise And Note Written Off DerivativeLiabilitiesReclassToAdditionalPaidInCapitalDueToNoteConversionWarrantExerciseAndNoteWrittenOff	2064422	usd
CY2022	boty	Shares Of Common Stock Issued For Conversion Of Debt And Accrued Interest SharesOfCommonStockIssuedForConversionOfDebtAndAccruedInterest	0	usd
CY2021	boty	Shares Of Common Stock Issued For Conversion Of Debt And Accrued Interest SharesOfCommonStockIssuedForConversionOfDebtAndAccruedInterest	862062	usd
CY2022	boty	Shares Of Common Stock Issued For Exercise Of Warrants SharesOfCommonStockIssuedForExerciseOfWarrants	176412	usd
CY2021	boty	Shares Of Common Stock Issued For Exercise Of Warrants SharesOfCommonStockIssuedForExerciseOfWarrants	267439	usd
CY2022	boty	Write Off Of Convertible Notes And Accrued Interest WriteOffOfConvertibleNotesAndAccruedInterest	0	usd
CY2021	boty	Write Off Of Convertible Notes And Accrued Interest WriteOffOfConvertibleNotesAndAccruedInterest	110076	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3535302536	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company continually evaluates its estimates and judgments. The Company bases its estimates and judgments on historical experience and other factors that it believes to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.</p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10009	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34481	usd
CY2022	us-gaap	Revenues Revenues	113802	usd
CY2021	us-gaap	Revenues Revenues	95436	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	33831	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	96245	usd
CY2022	us-gaap	Gross Profit GrossProfit	79971	usd
CY2021	us-gaap	Gross Profit GrossProfit	-809	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5664213958	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5906241545	shares
CY2022	boty	Related Party Balances And Transactionspolicytextblock RelatedPartyBalancesAndTransactionspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows FASB ASC 850, “<em>Related Party Disclosures</em>,” for the identification of related parties and disclosure of related party transaction. (See Note 9)</p>
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2967243	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5323107	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	51	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	51	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3711714036	shares
CY2020Q4	boty	Outstanding Warrants Balances Beginning OutstandingWarrantsBalancesBeginning	5438166666	shares
CY2021Q4	boty	Outstanding Warrants Exercise Price OutstandingWarrantsExercisePrice	0.0001
CY2021	boty	Granted Granted	400000000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0002
CY2021	boty	Redeemed Per Share RedeemedPerShare	0
CY2021	boty	Exercised Exercised	-281500000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0003
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5556666666	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0001
CY2022	boty	Granted Granted	282080000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0005
CY2022	boty	Redeemed Per Share RedeemedPerShare	0
CY2022	boty	Exercised Exercised	-201613143	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.0001
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5637133523	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0001
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	176411500	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	201613143	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	267438920	shares
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	281500000	shares
CY2021	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	400000000	shares
CY2022	boty	Warrants Granted For Promissory Note WarrantsGrantedForPromissoryNote	340000	usd
CY2022	boty	Expected Term ExpectedTerm	P2Y11M23D
CY2021	boty	Expected Term ExpectedTerm	P3Y9M14D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	976677	usd
CY2022Q4	boty	Closing Market Price ClosingMarketPrice	0.0003
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5637133523	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5556666666	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1683773	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4444017	shares
CY2022Q4	us-gaap	Notes Payable NotesPayable	340000	usd
CY2022Q4	boty	Promissory Notes To Auctus Fund PromissoryNotesToAuctusFund	340000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	89183	usd
CY2021Q4	boty	Promissory Notes To Auctus Fund PromissoryNotesToAuctusFund	340000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	250817	usd
CY2021Q1	boty	Debt Instrument Aggregate Discount DebtInstrumentAggregateDiscount	300000	usd
CY2021Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	35000	usd
CY2021Q1	boty	Warrants Derivative Amount WarrantsDerivativeAmount	265000	usd
CY2021Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	248077	usd
CY2021Q4	boty	Debt Instrument Aggregate Discount DebtInstrumentAggregateDiscount	40000	usd
CY2021Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	9000	usd
CY2021Q4	boty	Warrants Derivative Amount WarrantsDerivativeAmount	31000	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2740	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	584729	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	549010	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3095	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5323107	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	-67670	usd
CY2022	boty	Reduction Of Derivative Liabilities From Exercise Of Warrants ReductionOfDerivativeLiabilitiesFromExerciseOfWarrants	-116486	usd
CY2022	boty	Addition Of New Derivative Liabilities Upon Issuance Of Warrants As Debt Discount AdditionOfNewDerivativeLiabilitiesUponIssuanceOfWarrantsAsDebtDiscount	131190	usd
CY2022	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	125714	usd
CY2022	boty	Gain Loss On Change In Fair Value Of The Derivative Liability GainLossOnChangeInFairValueOfTheDerivativeLiability	-2428612	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2967243	usd
CY2022	boty	Loss Due To Derivative Liabilities On Convertible Notes And Warrants LossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants	125714	usd
CY2021	boty	Loss Due To Derivative Liabilities On Convertible Notes And Warrants LossDueToDerivativeLiabilitiesOnConvertibleNotesAndWarrants	385964	usd
CY2022	boty	Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants	-2428613	usd
CY2021	boty	Gain Loss On Change In Fair Value Of Derivative Liabilities On Convertible Notes And Warrants GainLossOnChangeInFairValueOfDerivativeLiabilitiesOnConvertibleNotesAndWarrants	2095436	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-2302899	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2481400	usd
CY2022Q4	boty	Amount Due To Related Parties AmountDueToRelatedParties	542668	usd
CY2021Q4	boty	Amount Due To Related Parties AmountDueToRelatedParties	465168	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4345599	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3820405	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	912576	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	802285	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	912576	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	802285	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	boty	Net Operating Loss Carryforward NetOperatingLossCarryforward	4300000	usd
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	begin to expire between 2034 and 2037
CY2022	boty	Net Operating Loss Carry Forwards Annual Limitation NetOperatingLossCarryForwardsAnnualLimitation	0.50	pure

Files In Submission

Name	View Source	Status
0001640334-23-001322-index-headers.html	Edgar Link	pending
0001640334-23-001322-index.html	Edgar Link	pending
0001640334-23-001322.txt	Edgar Link	pending
0001640334-23-001322-xbrl.zip	Edgar Link	pending
boty-20221231.xsd	Edgar Link	pending
boty_10k.htm	Edgar Link	pending
boty_ex101.htm	Edgar Link	pending
boty_ex101img1.jpg	Edgar Link	pending
boty_ex101img2.jpg	Edgar Link	pending
boty_ex102.htm	Edgar Link	pending
boty_ex102img3.jpg	Edgar Link	pending
boty_ex102img4.jpg	Edgar Link	pending
boty_ex102img5.jpg	Edgar Link	pending
boty_ex102img6.jpg	Edgar Link	pending
boty_ex103.htm	Edgar Link	pending
boty_ex103img11.jpg	Edgar Link	pending
boty_ex103img12.jpg	Edgar Link	pending
boty_ex103img13.jpg	Edgar Link	pending
boty_ex103img14.jpg	Edgar Link	pending
boty_ex103img15.jpg	Edgar Link	pending
boty_ex103img16.jpg	Edgar Link	pending
boty_ex103img17.jpg	Edgar Link	pending
boty_ex103img18.jpg	Edgar Link	pending
boty_ex103img19.jpg	Edgar Link	pending
boty_ex103img20.jpg	Edgar Link	pending
boty_ex103img21.jpg	Edgar Link	pending
boty_ex104.htm	Edgar Link	pending
boty_ex104img19.jpg	Edgar Link	pending
boty_ex104img20.jpg	Edgar Link	pending
boty_ex104img21.jpg	Edgar Link	pending
boty_ex104img22.jpg	Edgar Link	pending
boty_ex104img23.jpg	Edgar Link	pending
boty_ex104img24.jpg	Edgar Link	pending
boty_ex104img25.jpg	Edgar Link	pending
boty-20221231_def.xml	Edgar Link	unprocessable
boty-20221231_lab.xml	Edgar Link	unprocessable
boty-20221231_pre.xml	Edgar Link	unprocessable
boty_10k_htm.xml	Edgar Link	completed
boty_ex104img26.jpg	Edgar Link	pending
boty_ex104img27.jpg	Edgar Link	pending
boty_ex104img28.jpg	Edgar Link	pending
boty_ex104img29.jpg	Edgar Link	pending
boty_ex104img30.jpg	Edgar Link	pending
boty_ex104img31.jpg	Edgar Link	pending
boty_ex104img32.jpg	Edgar Link	pending
boty_ex104img33.jpg	Edgar Link	pending
boty_ex104img34.jpg	Edgar Link	pending
boty_ex104img35.jpg	Edgar Link	pending
boty_ex104img36.jpg	Edgar Link	pending
boty_ex104img37.jpg	Edgar Link	pending
boty_ex104img38.jpg	Edgar Link	pending
boty_ex104img39.jpg	Edgar Link	pending
boty_ex105.htm	Edgar Link	pending
boty_ex105img78.jpg	Edgar Link	pending
boty_ex105img79.jpg	Edgar Link	pending
boty_ex105img80.jpg	Edgar Link	pending
boty_ex105img81.jpg	Edgar Link	pending
boty_ex105img82.jpg	Edgar Link	pending
boty_ex105img83.jpg	Edgar Link	pending
boty_ex105img84.jpg	Edgar Link	pending
boty_ex105img85.jpg	Edgar Link	pending
boty_ex105img86.jpg	Edgar Link	pending
boty_ex105img87.jpg	Edgar Link	pending
boty_ex105img88.jpg	Edgar Link	pending
boty_ex105img89.jpg	Edgar Link	pending
boty_ex105img90.jpg	Edgar Link	pending
boty_ex105img91.jpg	Edgar Link	pending
boty_ex105img92.jpg	Edgar Link	pending
boty_ex105img93.jpg	Edgar Link	pending
boty_ex105img94.jpg	Edgar Link	pending
boty_ex105img95.jpg	Edgar Link	pending
boty_ex105img96.jpg	Edgar Link	pending
boty_ex105img97.jpg	Edgar Link	pending
boty_ex105img98.jpg	Edgar Link	pending
boty_ex106.htm	Edgar Link	pending
boty_ex106img1.jpg	Edgar Link	pending
boty_ex106img2.jpg	Edgar Link	pending
boty_ex106img3.jpg	Edgar Link	pending
boty_ex107.htm	Edgar Link	pending
boty_ex107img21.jpg	Edgar Link	pending
boty_ex107img22.jpg	Edgar Link	pending
boty_ex107img23.jpg	Edgar Link	pending
boty_ex107img24.jpg	Edgar Link	pending
boty_ex107img25.jpg	Edgar Link	pending
boty_ex107img26.jpg	Edgar Link	pending
boty_ex107img27.jpg	Edgar Link	pending
boty_ex107img28.jpg	Edgar Link	pending
boty_ex107img29.jpg	Edgar Link	pending
boty_ex107img30.jpg	Edgar Link	pending
boty_ex107img31.jpg	Edgar Link	pending
boty_ex108.htm	Edgar Link	pending
boty_ex108img1.jpg	Edgar Link	pending
boty_ex108img10.jpg	Edgar Link	pending
boty_ex108img11.jpg	Edgar Link	pending
boty_ex108img12.jpg	Edgar Link	pending
boty_ex108img13.jpg	Edgar Link	pending
boty_ex108img14.jpg	Edgar Link	pending
boty_ex108img15.jpg	Edgar Link	pending
boty_ex108img16.jpg	Edgar Link	pending
boty_ex108img17.jpg	Edgar Link	pending
boty_ex108img18.jpg	Edgar Link	pending
boty_ex108img19.jpg	Edgar Link	pending
boty_ex108img2.jpg	Edgar Link	pending
boty_ex108img20.jpg	Edgar Link	pending
boty_ex108img21.jpg	Edgar Link	pending
boty_ex108img22.jpg	Edgar Link	pending
boty_ex108img23.jpg	Edgar Link	pending
boty_ex108img3.jpg	Edgar Link	pending
boty_ex108img4.jpg	Edgar Link	pending
boty_ex108img5.jpg	Edgar Link	pending
boty_ex108img6.jpg	Edgar Link	pending
boty_ex108img7.jpg	Edgar Link	pending
boty_ex108img8.jpg	Edgar Link	pending
boty_ex108img9.jpg	Edgar Link	pending
boty_ex109.htm	Edgar Link	pending
boty_ex311.htm	Edgar Link	pending
boty_ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
boty-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

2022 Q4 Form 10-K Financial Statement

#000164033423001322 Filed on July 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOTY LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty

2022 Q4 Form 10-K Financial Statement

#000164033423001322 Filed on July 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOTY
LINGERIE FIGHTING CHAMPIONSHIPS, INC. Stock $boty